Seeing some dollar selling as hopes for a vaccine improve

Stocks higher and hopes are higher after Gilead remdesivir drug trials
Gilead chief medical officer Merdad Parsey said in a statement. "The study demonstrates the potential for some patients to be treated with a 5-day regimen, which could significantly expand the number of patients who could be treated with our current supply of remdesivir."